HUBEI PROVINCE, China--(BUSINESS WIRE)--Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTCBB:BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, announced today that its Ebei plant received Good Manufacturing Practices (GMP) certification for its new tablets product line on November 26, 2007. The GMP certification clears the tablets for mass production and sale, marking the official conclusion of the plant’s dramatic capacity expansion and beginning its significant product line growth.
